» Articles » PMID: 2066544

Early Gastric Cancer: a Clinicopathologic Study

Overview
Specialty Gastroenterology
Date 1991 Jun 1
PMID 2066544
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

We report our experience, between 1973 and 1989 of 302 patients with gastric cancer in a Dutch general hospital. In 144 (47.7%) of them gastric resection was performed. Twenty-eight patients had early gastric cancer (EGC) (9.3% of the entire series and 19.4% of the resected specimens). Multicentricity of EGC was noted in 3 patients (10.7%). The incidence of EGC decreased slightly during consecutive 8-year intervals. There were 16 men and 12 women (mean age 64 and 66 years, respectively). Standard biphasic contrast radiographic studies of the upper gastrointestinal tract diagnosed or suggested malignancy in all but one patient. Endoscopy with directed biopsy diagnosed malignancy in all patients. Twenty-one lesions (67.7%) were localized to the antral region. Type IIc was most frequent (38.7%). There were 21 intestinal-type and 10 diffuse-type EGC by the Lauren classification. The incidence of intestinal-type EGC decreased during two consecutive 8-year periods. All type I and IIa lesions were of the intestinal type, whereas all diffuse-type EGCs were either type IIc or III. Lymph node metastasis was observed in 9.7% of the lesions. The incidence of lymph node metastasis increased from 0% in mucosal cancer to 20% in submucosal cancer. The overall 5-year survival rate was 91.3%: (diffuse type 100% and intestinal type 85.7%). The 5-year survival rate was 100% in mucosal cancer and 81.8% in submucosal cancer.

Citing Articles

Peripheral Blood Inflammatory Markers as A Reliable Predictor of Gastric Mucosal Metaplasia Change in the Middle-aged Population.

Lai C, Lee C, Yeh T, Chang M, Lin Y, Chen T J Cancer. 2024; 15(11):3313-3320.

PMID: 38817866 PMC: 11134446. DOI: 10.7150/jca.95159.


Upper Gastrointestinal Cancer: Delays in Diagnosis and Treatment Caused by Barriers to Healthcare in the Latino Community.

Montalvan-Sanchez E, Beas R, Norwood D, Alkashash A, Rodriguez Murillo A, Calderon G Gastroenterology Res. 2022; 15(3):142-147.

PMID: 35836703 PMC: 9239493. DOI: 10.14740/gr1514.


A Novel Six-Gene-Based Prognostic Model Predicts Survival and Clinical Risk Score for Gastric Cancer.

Li J, Pu K, Li C, Wang Y, Zhou Y Front Genet. 2021; 12:615834.

PMID: 33692828 PMC: 7938863. DOI: 10.3389/fgene.2021.615834.


Mir-421 in plasma as a potential diagnostic biomarker for precancerous gastric lesions and early gastric cancer.

Chen J, Wu L, Sun Y, Yin Q, Chen X, Liang S PeerJ. 2019; 7:e7002.

PMID: 31245174 PMC: 6585904. DOI: 10.7717/peerj.7002.


Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area.

Gantuya B, Oyuntsetseg K, Bolor D, Erdene-Ochir Y, Sanduijav R, Davaadorj D Gastric Cancer. 2018; 22(1):104-112.

PMID: 29934751 DOI: 10.1007/s10120-018-0844-8.